Hôpital Européen Georges Pompidou - AP-HP

69 currently recruiting clinical trials
Create patient profile for matching
Phase 1 Lung cancer #NCT06026410
Bras 7 (CBNPC KRAS G12C)
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required histologic sub types
Non-squamous NSCLC
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
KRAS G12C
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Kura Oncologie, Inc.
Phase 1 Kidney cancer #NCT06026410
Bras 4, 5 et 6 Carcinome rénal à cellules claires (CRCC)
Required histologic types
Clear cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Kura Oncologie, Inc.
Phase 1 Breast cancer Lung cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05403554 #2021-003808-40
Cohorte monothérapie
Required histologic types
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer
Required histologic sub types
Non-squamous NSCLC Serous high grade carcinoma (HGSOC) Endometrioid carcinoma
Required HER2 statuses
HER2 Negative HER2 Positive
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Light Chain Bioscience - Novimmune SA
Phase 1 Kidney cancer #NCT06026410
Bras 2 CCR localement avancé ou métastatique
Required histologic types
Clear cell carcinoma Papillary carcinoma Chromophobe carcinoma Other
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None 1 2 3 or more
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Kura Oncologie, Inc.
Phase 1
Matches all main criterias
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Not Applicable Bladder / Urinary Tract / Urethral cancer #NCT05002556
Required histologic types
Non-invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Localized
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Association Française d'Urologie
Not Applicable Colon cancer Rectal cancer #NCT05639413
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required genetic anomalies
BRAF
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Chemotherapy
Hôpital Européen Georges Pompidou - AP-HP (Paris)
UNICANCER
Not Applicable #NCT01689584
Required genetic anomalies
Other mutation BRCA 1/2 CDH1 MSI/dMMR POLE PTEN SMAD4 TP53
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Institut Curie
Not Applicable Lung cancer #NCT06053099
Single Cohort
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Localized
Required genetic anomalies
EGFR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive Surgery
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Intergroupe Francophone de Cancérologie Thoracique